Empliciti Interactions
There are 260 drugs known to interact with Empliciti (elotuzumab), along with 1 disease interaction. Of the total drug interactions, 49 are major, and 211 are moderate.
- View all 260 medications that may interact with Empliciti
- View Empliciti disease interactions (1)
Most frequently checked interactions
View interaction reports for Empliciti (elotuzumab) and the medicines listed below.
- acyclovir
- Adcetris (brentuximab)
- Adriamycin RDF (doxorubicin)
- Alprolix (coagulation factor ix)
- aspirin
- Benlysta (belimumab)
- Besponsa (inotuzumab ozogamicin)
- bleomycin
- Blincyto (blinatumomab)
- CellCept (mycophenolate mofetil)
- Complera (emtricitabine / rilpivirine / tenofovir)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- cyclophosphamide
- Cymbalta (duloxetine)
- dapsone
- daratumumab
- Darzalex (daratumumab)
- dexamethasone
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Ocrevus (ocrelizumab)
- omeprazole
- Pomalyst (pomalidomide)
- Ravicti (glycerol phenylbutyrate)
- Repatha (evolocumab)
- Revlimid (lenalidomide)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
Empliciti disease interactions
There is 1 disease interaction with Empliciti (elotuzumab) which include:
More about Empliciti (elotuzumab)
- Empliciti consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.